Pubblicazioni

Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients

2021 - ANNALS OF HEMATOLOGY

Scalzulli, E.; Caocci, G.; Efficace, F.; Rizzo, L.; Colafigli, G.; Di Prima, A.; Pepe, S.; Fegatelli, D. A.; Carmosino, I.; Diverio, D.; Latagliata, R.; La Nasa, G.; Martelli, M.; Foa, R.; Breccia, M.

Ibrutinib-based therapy impaired neutrophils microbicidal activity in patients with chronic lymphocytic leukemia during the early phases of treatment

2019 - LEUKEMIA RESEARCH

Prezzo, A.; Cavaliere, F. M.; Bilotta, C.; Pentimalli, T. M.; Iacobini, M.; Cesini, L.; Foa, R.; Mauro, F. R.; Quinti, I.

Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARÎ±) in Non-Somatotroph Pituitary Tumours and the Effects of PPARÎ± Agonists on MMQ Cells

2018 - HORMONE AND METABOLIC RESEARCH

Polidoro, Michela Anna; Rotondi, Sandra; Morace, Roberta; Rostomyan, Liliya; Colapietro, Alessandro; Arcella, Antonietta; Ventura, Luca; Angelucci, Adriano; Giangaspero, Felice; Esposito, Vincenzo; Beckers, Albert; Jaffrain-Rea, Marie-Lise

Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

2015 - INTERNATIONAL JOURNAL OF CARDIOLOGY

Marra, ALBERTO MARIA; Egenlauf, Benjamin; Ehlken, Nicola; Fischer, Christine; Eichstaedt, Christina; Nagel, Christian; Bossone, Eduardo; Cittadini, Antonio; Halank, Michael; Gall, Henning; Olsson, Karen M; Lange, Tobias J; GrÃ¼nig, Ekkehard